BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 36266760)

  • 1. Inclusion of a core patient-reported outcomes battery in adolescent and young adult cancer clinical trials.
    Roth ME; Parsons SK; Ganz PA; Wagner LI; Hinds PS; Alexander S; Bingen K; Bober SL; Brackett J; Cella D; Henry NL; Indelicato DJ; Johnson RH; Miller TP; Rosenberg SM; Schmitz KH; Thanarajasingam G; Reeve BB; Salsman JM
    J Natl Cancer Inst; 2023 Jan; 115(1):21-28. PubMed ID: 36266760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inclusion of Patient-Reported Outcomes in Adolescent and Young Adult Phase III Therapeutic Trials: An Analysis of Cancer Clinical Trials Registered on ClinicalTrials.gov.
    Berkman AM; Murphy KM; Siembida EJ; Lau N; Geng Y; Parsons SK; Salsman JM; Roth ME
    Value Health; 2021 Dec; 24(12):1820-1827. PubMed ID: 34838280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring health-related quality of life in adolescent and young adult cancer survivors with the National Institutes of Health Patient-Reported Outcomes Measurement Information System
    Siembida EJ; Reeve BB; Zebrack BJ; Snyder MA; Salsman JM
    Psychooncology; 2021 Mar; 30(3):303-311. PubMed ID: 33073416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Patient-Reported Health-Related Quality of Life With Physician-Reported Toxicities in Adolescents and Young Adults Receiving Radiation Therapy for Cancer.
    Corrigan KL; Reeve BB; Salsman JM; Siembida EJ; Smith GL; Swartz MC; Lee KL; Afridi F; Andring LM; Bishop AJ; Gunther JR; Livingston JA; Peterson SK; Parsons SK; Roth M
    JCO Oncol Pract; 2023 Aug; 19(8):610-619. PubMed ID: 37311165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review of health-related quality of life outcomes in psychosocial intervention trials for adolescent and young adult cancer survivors.
    Murphy KM; Siembida E; Lau N; Berkman A; Roth M; Salsman JM
    Crit Rev Oncol Hematol; 2023 Aug; 188():104045. PubMed ID: 37269881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding Causes of Inferior Outcomes in Adolescents and Young Adults With Cancer.
    Wolfson JA; Kenzik KM; Foxworthy B; Salsman JM; Donahue K; Nelson M; Littrell MB; Williams GR; Levine JM
    J Natl Compr Canc Netw; 2023 Aug; 21(8):881-888. PubMed ID: 37549915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Adolescents' and Young Adults' Attitudes Toward Participation in Cancer Clinical Trials.
    Lewin J; Bell JAH; Wang K; Forcina V; Tam S; Srikanthan A; Lin YC; Taback N; Mitchell L; Gupta AA
    JCO Oncol Pract; 2020 Mar; 16(3):e280-e289. PubMed ID: 32048946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review of barriers and facilitators to clinical trial enrollment among adolescents and young adults with cancer: Identifying opportunities for intervention.
    Siembida EJ; Loomans-Kropp HA; Trivedi N; O'Mara A; Sung L; Tami-Maury I; Freyer DR; Roth M
    Cancer; 2020 Mar; 126(5):949-957. PubMed ID: 31869454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related quality of life in adolescents and young adults with cancer who received radiation therapy: a scoping review.
    Corrigan KL; Reeve BB; Salsman JM; Siembida EJ; Andring LM; Geng Y; Kouzy R; Livingston JA; Peterson SK; Bishop AJ; Smith GL; Gunther JR; Parsons SK; Roth M
    Support Care Cancer; 2023 Mar; 31(4):230. PubMed ID: 36961516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicity of Cancer Therapy in Adolescents and Young Adults (AYAs).
    Bukowinski AJ; Burns KC; Parsons K; Perentesis JP; O'Brien MM
    Semin Oncol Nurs; 2015 Aug; 31(3):216-26. PubMed ID: 26210200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AYA Considerations for Aggressive Lymphomas.
    Llaurador G; Giulino-Roth L
    Curr Hematol Malig Rep; 2021 Feb; 16(1):61-71. PubMed ID: 33728589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Creation of a quality improvement collaborative to address adolescent and young adult cancer clinical trial enrollment: ATAQI (AYA trial access quality initiative).
    Hesko C; Mittal N; Avutu V; Thomas SM; Heath JL; Roth ME
    Curr Probl Cancer; 2023 Dec; 47(6):100898. PubMed ID: 36207194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adolescent and young adult (AYA) lymphoma survivors report lower health-related quality of life compared to a normative population: results from the PROFILES registry.
    Husson O; Prins JB; Kaal SE; Oerlemans S; Stevens WB; Zebrack B; van der Graaf WT; van de Poll-Franse LV
    Acta Oncol; 2017 Feb; 56(2):288-294. PubMed ID: 28077017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What do adolescents and young adults want from cancer resources? Insights from a Delphi panel of AYA patients.
    Cheung CK; Zebrack B
    Support Care Cancer; 2017 Jan; 25(1):119-126. PubMed ID: 27580714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective comparison of cancer clinical trial availability and enrollment among adolescents/young adults treated at an adult cancer hospital or affiliated children's hospital.
    Thomas SM; Malvar J; Tran HH; Shows JT; Freyer DR
    Cancer; 2018 Oct; 124(20):4064-4071. PubMed ID: 30291804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-related quality of life profiles in adolescents and young adults with chronic conditions.
    Wang S; Arizmendi CJ; Blalock DV; Chen D; Lin L; Thissen D; Huang IC; DeWalt DA; Reeve BB
    Qual Life Res; 2023 Nov; 32(11):3171-3183. PubMed ID: 37340132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Danish Translation and Linguistic Validation of the U.S. National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).
    Bæksted C; Nissen A; Pappot H; Bidstrup PE; Mitchell SA; Basch E; Dalton SO; Johansen C
    J Pain Symptom Manage; 2016 Aug; 52(2):292-7. PubMed ID: 27090851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unmet Support Service Needs and Health-Related Quality of Life among Adolescents and Young Adults with Cancer: The AYA HOPE Study.
    Smith AW; Parsons HM; Kent EE; Bellizzi K; Zebrack BJ; Keel G; Lynch CF; Rubenstein MB; Keegan TH;
    Front Oncol; 2013; 3():75. PubMed ID: 23580328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.